Most Recent

image: Clinical Trial Misfortune

Clinical Trial Misfortune

By | August 28, 2012

A human trial of a hepatitis C treatment is shut down after one of the participants died.

1 Comment

image: Orphan Drugs Lucrative

Orphan Drugs Lucrative

By | August 24, 2012

The market for drugs that target rare diseases is expected to rival big pharma blockbusters in the coming decades.

1 Comment

image: Curiouser and Curiouser

Curiouser and Curiouser

By | August 23, 2012

A review of the new book Curious Behavior, which delves into the quirks of human conduct.

7 Comments

image: Zoo Virus Swap

Zoo Virus Swap

By | August 17, 2012

A polar bear in a German zoo dies after contracting a virus normally found in zebras.

3 Comments

image: Court Rules Gene Patents Valid

Court Rules Gene Patents Valid

By | August 17, 2012

Myriad Genetics can hold patents on the BRAC1 and BRAC2 oncogenes, but not on tests comparing DNA sequences.

8 Comments

image: Hope for Male Contraception

Hope for Male Contraception

By | August 16, 2012

A small molecule that inhibits a protein important for chromatin organization can cause reversible sterility in male mice.

0 Comments

image: Pharma Whistleblower

Pharma Whistleblower

By | August 16, 2012

A former manager at Genentech claims the company bypassed ethical and clinical guidelines in order to rush a promising drug through clinical trials.

1 Comment

image: Do That Again

Do That Again

By | August 15, 2012

A new initiative offers gold stars to researchers willing to have their studies replicated by other labs, but will it fix science’s growing irreproducibility problem?

9 Comments

image: More Mutations in Fukushima Butterflies

More Mutations in Fukushima Butterflies

By | August 15, 2012

Researchers have found an increase in butterflies with unusual wing shapes, legs, and antennae than before the nuclear disaster.

0 Comments

image: Sanctioned Psychiatrist Off Restriction

Sanctioned Psychiatrist Off Restriction

By | August 14, 2012

Charles Nemeroff, who was barred from receiving grants for 2 years in 2008, snags $401K from the NIH to study PTSD.

1 Comment

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
Advertisement
NeuroScientistNews
NeuroScientistNews